Ridgetech, Inc. RDGT

Annual Quarterly

FY2026 · ended Mar 31, 2026 · Revenue $132.16M, +10.2% YoY · Filed Jul 31, 2026

Ridgetech, Inc. (RDGT) files with the SEC under industry code 5912, Retail-Drug Stores and Proprietary Stores. In fiscal 2026, which ended Mar 31, 2026, it reported revenue of $132.2 million and a net loss of $1.3 million. Free cash flow was -$1.4 million.

Revenue
$132.16M
+10.2% vs prior year
Net income
$-1.25M
-112.3% vs prior year
Operating cash flow
$-1.39M
-211.7% vs prior year
Free cash flow
$-1.39M
-227.6% vs prior year
EPS
$-17.21
-106.2% vs prior year
Dividend per share
None
Shares outstanding
133.09M
+2173.1% vs prior year
Net cash
$-8.05M
FY 2024
Operating margin
-1.4%
FY 2026

Company profile

Industry
Retail-Drug Stores and Proprietary Stores (SIC 5912)
Listed as
RDGT (Nasdaq)
Fiscal year ends
March 31
Incorporated in
Cayman Islands
Headquarters
Hangzhou City, China
SEC filer status
Non-accelerated filer
SEC CIK
1856084
Former names
China Jo-Jo Drugstores, Inc. (until Feb 5, 2025); China Jo-Jo Drugstores Holdings, Inc. (until Jun 16, 2023)

Other Retail-Drug Stores and Proprietary Stores companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
Revenue
$132.2M
$120.0M
$124.0M
$120.2M
$164.4M
Operating income
-$1.9M
-$1.0M
$596,082
-$13.2M
-$2.7M
Net income
-$1.3M
$10.2M
-$4.2M
-$21.1M
-$3.2M
Diluted EPS
-$17.21
$275.87
-$439.78
-$41.46
-$18.35
Operating cash flow
-$1.4M
$1.2M
-$3.2M
-$3.3M
-$5.4M
Free cash flow
-$1.4M
$1.1M
-$3.5M
-$3.4M
-$5.5M
Total assets
$69.0M
$64.5M
$95.1M
$91.0M
$106.4M
Total liabilities
$28.3M
$34.8M
$80.8M
$74.3M
$83.6M
Stockholders' equity
$40.8M
$29.6M
$14.3M
$16.7M
$22.7M
Cash and investments
$17.9M
$12.8M
$3.5M
$20.6M
$23.0M
Total debt
—
—
$11.5M
$12.9M
$12.5M

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Sep 9, 2026 Sep 9, 2026
6-K Current report (foreign issuer) Sep 1, 2026 Sep 1, 2026
6-K Current report (foreign issuer) Aug 28, 2026 Aug 28, 2026
6-K Current report (foreign issuer) Aug 5, 2026 Aug 5, 2026
20-F Annual report (foreign issuer) Jul 31, 2026 Mar 31, 2026
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.